These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26198655)

  • 1. Dose or 'LET' painting--What is optimal in particle therapy of hypoxic tumors?
    Malinen E; Søvik Å
    Acta Oncol; 2015; 54(9):1614-22. PubMed ID: 26198655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LET-painting increases tumour control probability in hypoxic tumours.
    Bassler N; Toftegaard J; Lühr A; Sørensen BS; Scifoni E; Krämer M; Jäkel O; Mortensen LS; Overgaard J; Petersen JB
    Acta Oncol; 2014 Jan; 53(1):25-32. PubMed ID: 24020629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose- and LET-painting with particle therapy.
    Bassler N; Jäkel O; Søndergaard CS; Petersen JB
    Acta Oncol; 2010 Oct; 49(7):1170-6. PubMed ID: 20831510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon beam therapy overcomes the radiation resistance of uterine cervical cancer originating from hypoxia.
    Nakano T; Suzuki Y; Ohno T; Kato S; Suzuki M; Morita S; Sato S; Oka K; Tsujii H
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2185-90. PubMed ID: 16609033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton vs carbon ion beams in the definitive radiation treatment of cancer patients.
    Suit H; DeLaney T; Goldberg S; Paganetti H; Clasie B; Gerweck L; Niemierko A; Hall E; Flanz J; Hallman J; Trofimov A
    Radiother Oncol; 2010 Apr; 95(1):3-22. PubMed ID: 20185186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of radiation quality on the risks of second malignancies.
    Manem VS; Kohandel M; Hodgson DC; Sharpe MB; Sivaloganathan S
    Int J Radiat Biol; 2015 Mar; 91(3):209-17. PubMed ID: 25356906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cellular lethality in DNA repair-proficient or -deficient cell lines resulting from exposure to 70 MeV/n protons or 290 MeV/n carbon ions.
    Genet SC; Maeda J; Fujisawa H; Yurkon CR; Fujii Y; Romero AM; Genik PC; Fujimori A; Kitamura H; Kato TA
    Oncol Rep; 2012 Nov; 28(5):1591-6. PubMed ID: 22923057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour control in ion beam radiotherapy with different ions in the presence of hypoxia: an oxygen enhancement ratio model based on the microdosimetric kinetic model.
    Strigari L; Torriani F; Manganaro L; Inaniwa T; Dalmasso F; Cirio R; Attili A
    Phys Med Biol; 2018 Mar; 63(6):065012. PubMed ID: 28862152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical oxygen enhancement ratio of tumors in carbon ion radiotherapy: the influence of local oxygenation changes.
    Antonovic L; Lindblom E; Dasu A; Bassler N; Furusawa Y; Toma-Dasu I
    J Radiat Res; 2014 Sep; 55(5):902-11. PubMed ID: 24728013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling of the oxygen enhancement ratio for ion beam radiation therapy.
    Wenzl T; Wilkens JJ
    Phys Med Biol; 2011 Jun; 56(11):3251-68. PubMed ID: 21540489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MONTE CARLO SIMULATIONS OF SPATIAL LET DISTRIBUTIONS IN CLINICAL PROTON BEAMS.
    Grzanka L; Ardenfors O; Bassler N
    Radiat Prot Dosimetry; 2018 Aug; 180(1-4):296-299. PubMed ID: 29378068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theoretical analysis of the dose dependence of the oxygen enhancement ratio and its relevance for clinical applications.
    Wenzl T; Wilkens JJ
    Radiat Oncol; 2011 Dec; 6():171. PubMed ID: 22172079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photon and Proton Dose Painting Based on Oxygen Distribution - Feasibility Study and Tumour Control Probability Assessment.
    Ureba A; Ödén J; Toma-Dasu I; Lazzeroni M
    Adv Exp Med Biol; 2022; 1395():223-228. PubMed ID: 36527641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Monte Carlo study for the calculation of the average linear energy transfer (LET) distributions for a clinical proton beam line and a radiobiological carbon ion beam line.
    Romano F; Cirrone GA; Cuttone G; Rosa FD; Mazzaglia SE; Petrovic I; Fira AR; Varisano A
    Phys Med Biol; 2014 Jun; 59(12):2863-82. PubMed ID: 24828462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Particle radiation therapy using proton and heavier ion beams.
    Schulz-Ertner D; Tsujii H
    J Clin Oncol; 2007 Mar; 25(8):953-64. PubMed ID: 17350944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiobiological description of the LET dependence of the cell survival of oxic and anoxic cells irradiated by carbon ions.
    Antonovic L; Brahme A; Furusawa Y; Toma-Dasu I
    J Radiat Res; 2013 Jan; 54(1):18-26. PubMed ID: 22915783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The present and future of heavy charged particle therapy].
    Tsujii H
    Nihon Rinsho; 1996 Jan; 54(1):268-73. PubMed ID: 8587201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Response of lithium fluoride detector to charged particle LET].
    Wang GL; Qi ZN; Chen M; Huang ZX; Xu ZH
    Space Med Med Eng (Beijing); 2001 Apr; 14(2):154-6. PubMed ID: 11808573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: a modelling study.
    Søvik A; Malinen E; Bruland ØS; Bentzen SM; Olsen DR
    Phys Med Biol; 2007 Jan; 52(2):499-513. PubMed ID: 17202629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of optimized single and multifield irradiation plans of antiproton, proton and carbon ion beams.
    Bassler N; Kantemiris I; Karaiskos P; Engelke J; Holzscheiter MH; Petersen JB
    Radiother Oncol; 2010 Apr; 95(1):87-93. PubMed ID: 20304512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.